-
1
-
-
33747358308
-
Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
-
Stiller CA, Bielack SS, Jundt G and Steliarova–Foucher E: Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 42: 2124–2135, 2006.
-
(2006)
Eur J Cancer
, vol.42
, pp. 2124-2135
-
-
Stiller, C.A.1
Bielack, S.S.2
Jundt, G.3
-
2
-
-
0036467661
-
Prognostic factors in high–grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
-
Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al: Prognostic factors in high–grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776–790, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 776-790
-
-
Bielack, S.S.1
Kempf-Bielack, B.2
Delling, G.3
Exner, G.U.4
Flege, S.5
Helmke, K.6
Kotz, R.7
Salzer-Kuntschik, M.8
Werner, M.9
Winkelmann, W.10
-
3
-
-
0035694563
-
The different level of immunological recovery after chemotherapy in leukemia and lymphoma patients
-
Milosević DB: The different level of immunological recovery after chemotherapy in leukemia and lymphoma patients. J Exp Clin Cancer Res 20: 517–522, 2001.
-
(2001)
J Exp Clin Cancer Res
, vol.20
, pp. 517-522
-
-
Milosević, D.B.1
-
4
-
-
37349051718
-
Molecular characteristics of immunogenic cancer cell death
-
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L and Kroemer G: Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 15: 3–12, 2008.
-
(2008)
Cell Death Differ
, vol.15
, pp. 3-12
-
-
Tesniere, A.1
Panaretakis, T.2
Kepp, O.3
Apetoh, L.4
Ghiringhelli, F.5
Zitvogel, L.6
Kroemer, G.7
-
5
-
-
41549145181
-
Immunogenicity of anthracyclines: Moving towards more personalized medicine
-
Apetoh L, Mignot G, Panaretakis T, Kroemer G and Zitvogel L: Immunogenicity of anthracyclines: Moving towards more personalized medicine. Trends Mol Med 14: 141–151, 2008.
-
(2008)
Trends Mol Med
, vol.14
, pp. 141-151
-
-
Apetoh, L.1
Mignot, G.2
Panaretakis, T.3
Kroemer, G.4
Zitvogel, L.5
-
6
-
-
34948820602
-
Toll–like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
-
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al: Toll–like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature 13: 1050–1059, 2007.
-
(2007)
Nature
, vol.13
, pp. 1050-1059
-
-
Apetoh, L.1
Ghiringhelli, F.2
Tesniere, A.3
Obeid, M.4
Ortiz, C.5
Criollo, A.6
Mignot, G.7
Maiuri, M.C.8
Ullrich, E.9
Saulnier, P.10
-
7
-
-
79960406242
-
Human tumor cells killed by anthracyclines induce a tumor–specific immune response
-
Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J and Spísek R: Human tumor cells killed by anthracyclines induce a tumor–specific immune response. Cancer Res 71: 4821–4833, 2011.
-
(2011)
Cancer Res
, vol.71
, pp. 4821-4833
-
-
Fucikova, J.1
Kralikova, P.2
Fialova, A.3
Brtnicky, T.4
Rob, L.5
Bartunkova, J.6
Spísek, R.7
-
8
-
-
67249158956
-
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
-
Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I and Reis e Sousa C: Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458: 899–903, 2009.
-
(2009)
Nature
, vol.458
, pp. 899-903
-
-
Sancho, D.1
Joffre, O.P.2
Keller, A.M.3
Rogers, N.C.4
Martínez, D.5
Hernanz-Falcón, P.6
Rosewell, I.7
Reis E Sousa, C.8
-
9
-
-
37049031915
-
Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum
-
Lutz MB and Rössner S: Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum. Immunobiology 212: 855–862, 2007.
-
(2007)
Immunobiology
, vol.212
, pp. 855-862
-
-
Lutz, M.B.1
Rössner, S.2
-
10
-
-
77953288334
-
Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma
-
Kawano M, Nishida H, Nakamoto Y, Tsumura H and Tsuchiya H: Cryoimmunologic antitumor effects enhanced by dendritic cells in osteosarcoma. Clin Orthop Relat Res 468: 1373–1383, 2010.
-
(2010)
Clin Orthop Relat Res
, vol.468
, pp. 1373-1383
-
-
Kawano, M.1
Nishida, H.2
Nakamoto, Y.3
Tsumura, H.4
Tsuchiya, H.5
-
11
-
-
84866462218
-
Anti–TGF–β antibody combined with dendritic cells produce antitumor effects in osteosarcoma
-
Kawano M, Itonaga I, Iwasaki T, Tsuchiya H and Tsumura H: Anti–TGF–β antibody combined with dendritic cells produce antitumor effects in osteosarcoma. Clin Orthop Relat Res 470: 2288–2294, 2012.
-
(2012)
Clin Orthop Relat Res
, vol.470
, pp. 2288-2294
-
-
Kawano, M.1
Itonaga, I.2
Iwasaki, T.3
Tsuchiya, H.4
Tsumura, H.5
-
12
-
-
84872787611
-
Enhancement of antitumor immunity by combining anti–cytotoxic T lymphocyte antigen–4 antibodies and cryotreated tumor lysate–pulsed dendritic cells in murine osteosarcoma
-
Kawano M, Itonaga I, Iwasaki T and Tsumura H: Enhancement of antitumor immunity by combining anti–cytotoxic T lymphocyte antigen–4 antibodies and cryotreated tumor lysate–pulsed dendritic cells in murine osteosarcoma. Oncol Rep 29: 1001–1006, 2013.
-
(2013)
Oncol Rep
, vol.29
, pp. 1001-1006
-
-
Kawano, M.1
Itonaga, I.2
Iwasaki, T.3
Tsumura, H.4
-
13
-
-
79952390627
-
Immune parameters affecting the efficacy of chemotherapeutic regimens
-
Zitvogel L, Kepp O and Kroemer G: Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol 8: 151–160, 2011.
-
(2011)
Nat Rev Clin Oncol
, vol.8
, pp. 151-160
-
-
Zitvogel, L.1
Kepp, O.2
Kroemer, G.3
-
14
-
-
78049523304
-
Desirable cell death during anticancer chemotherapy
-
Locher C, Conforti R, Aymeric L, Ma Y, Yamazaki T, Rusakiewicz S, Tesnière A, Ghiringhelli F, Apetoh L, Morel Y, et al: Desirable cell death during anticancer chemotherapy. Ann N Y Acad Sci 1209: 99–108, 2010.
-
(2010)
Ann N Y Acad Sci
, vol.1209
, pp. 99-108
-
-
Locher, C.1
Conforti, R.2
Aymeric, L.3
Ma, Y.4
Yamazaki, T.5
Rusakiewicz, S.6
Tesnière, A.7
Ghiringhelli, F.8
Apetoh, L.9
Morel, Y.10
-
15
-
-
77953701142
-
Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway
-
Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N and Kroemer G: Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway. Clin Cancer Res 16: 3100–3104, 2010.
-
(2010)
Clin Cancer Res
, vol.16
, pp. 3100-3104
-
-
Zitvogel, L.1
Kepp, O.2
Senovilla, L.3
Menger, L.4
Chaput, N.5
Kroemer, G.6
-
16
-
-
33846057130
-
Calreticulin exposure dictates the immunogenicity of cancer cell death
-
Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, Castedo M, Mignot G, Panaretakis T, Casares N, et al: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 13: 54–61, 2007.
-
(2007)
Nat Med
, vol.13
, pp. 54-61
-
-
Obeid, M.1
Tesniere, A.2
Ghiringhelli, F.3
Fimia, G.M.4
Apetoh, L.5
Perfettini, J.L.6
Castedo, M.7
Mignot, G.8
Panaretakis, T.9
Casares, N.10
-
17
-
-
84902480051
-
Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
-
Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O and Kroemer G: Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology 3: e28276, 2014.
-
(2014)
Oncoimmunology
, vol.3
-
-
Michaud, M.1
Sukkurwala, A.Q.2
Di Sano, F.3
Zitvogel, L.4
Kepp, O.5
Kroemer, G.6
-
18
-
-
48549095188
-
Nucleic acid sensing toll–like receptors in dendritic cells
-
Hoshino K and Kaisho T: Nucleic acid sensing toll–like receptors in dendritic cells. Curr Opin Immunol 20: 408–413, 2008.
-
(2008)
Curr Opin Immunol
, vol.20
, pp. 408-413
-
-
Hoshino, K.1
Kaisho, T.2
-
19
-
-
0032816123
-
Proinflammatory cytokines (Tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein–1 by pituicytes
-
Wang H, Vishnubhakat JM, Bloom O, Zhang M, Ombrellino M, Sama A and Tracey KJ: Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein–1 by pituicytes. Surgery 126: 389–392, 1999.
-
(1999)
Surgery
, vol.126
, pp. 389-392
-
-
Wang, H.1
Vishnubhakat, J.M.2
Bloom, O.3
Zhang, M.4
Ombrellino, M.5
Sama, A.6
Tracey, K.J.7
-
20
-
-
0037062934
-
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
-
Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191–195, 2002.
-
(2002)
Nature
, vol.418
, pp. 191-195
-
-
Scaffidi, P.1
Misteli, T.2
Bianchi, M.E.3
-
21
-
-
1542380035
-
Involvement of toll–like receptors 2 and 4 in cellular activation by high mobility group box 1 protein
-
Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A and Abraham E: Involvement of toll–like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279: 7370–7377, 2004.
-
(2004)
J Biol Chem
, vol.279
, pp. 7370-7377
-
-
Park, J.S.1
Svetkauskaite, D.2
He, Q.3
Kim, J.Y.4
Strassheim, D.5
Ishizaka, A.6
Abraham, E.7
-
22
-
-
35748942876
-
The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
-
Apetoh L, Ghiringhelli F, Tesniere A, Criollo A, Ortiz C, Lidereau R, Mariette C, Chaput N, Mira JP, Delaloge S, et al: The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev 220: 47–59, 2007.
-
(2007)
Immunol Rev
, vol.220
, pp. 47-59
-
-
Apetoh, L.1
Ghiringhelli, F.2
Tesniere, A.3
Criollo, A.4
Ortiz, C.5
Lidereau, R.6
Mariette, C.7
Chaput, N.8
Mira, J.P.9
Delaloge, S.10
-
23
-
-
41149097574
-
Adoptive cell transfer: A clinical path to effective cancer immunotherapy
-
Rosenberg SA, Restifo NP, Yang JC, Morgan RA and Dudley ME: Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat Rev Cancer 8: 299–308, 2008.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 299-308
-
-
Rosenberg, S.A.1
Restifo, N.P.2
Yang, J.C.3
Morgan, R.A.4
Dudley, M.E.5
-
24
-
-
33751209215
-
Combined chemoimmunotherapy of solid tumours: Improving vaccines?
-
Nowak AK, Lake RA and Robinson BW: Combined chemoimmunotherapy of solid tumours: Improving vaccines? Adv Drug Deliv Rev 58: 975–990, 2006.
-
(2006)
Adv Drug Deliv Rev
, vol.58
, pp. 975-990
-
-
Nowak, A.K.1
Lake, R.A.2
Robinson, B.W.3
|